Opko Health Inc Expected To Post A Loss Of 9 Cents A Share: Earnings Preview

OPKO Health

29/04/2024 12:04

* OPKO Health Inc  OPK.OQ   OPK.O  is expected to show a
fall in
quarterly revenue when it reports  results on May 1 (estimated)
for the period ending March 31 2024
    * The Miami Florida-based  company is expected to report a
23.0% decrease in revenue to $182.99 million from $237.6 million
a year ago, according to the mean estimate from 6 analysts,
based on LSEG data.The company's guidance on February 27 2024,
for the period ended March 31, was for revenue between $180.00
million and $185.00 million.
    * ​LSEG's mean analyst estimate for OPKO Health Inc is for a
loss
of 9 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for OPKO Health
Inc
is $4.00​, above​ its last closing price of $1.26. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Dec. 31 2023  -0.09       -0.09      -0.09     Met     -2.3
 Sep. 30 2023  -0.09                  -0.11             -10
 Jun. 30 2023  -0.07       -0.07      -0.03     Beat    63.6​
 Mar. 31 2023  -0.08       -0.08      -0.02     Beat    73.9
 ​​Dec.        -0.11       -0.11      -0.11     Met     2.9
 31 2022                                                
 Sep. 30 2022  -0.08       -0.08      -0.11     Missed  -31​
 Jun. 30 2022  0.01        0.01       -0.14     Missed  -1,850
 Mar. 31 2022  -0.06       -0.06      -0.08     Missed  -42.9
 This summary was machine generated April 29 at 11:04 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)